Alkem Laboratories Limited has provided regulatory notice to both National Stock Exchange of India Limited and BSE Limited regarding an upcoming board meeting.
The meeting of the Board of Directors is scheduled to be held on Thursday, 12th November, 2026. The primary agenda item for this meeting is to consider and approve the company's financial results.
The board will review both:
- Standalone Unaudited Financial Results
- Consolidated Unaudited Financial Results
These results cover the financial period for the quarter and half year ended 30th September, 2026.
This disclosure is made in compliance with Regulation 29 read with Regulation 33 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015.
The notice was digitally signed by Manish Narang, who holds the position of President – Legal, Company Secretary & Compliance Officer of Alkem Laboratories Limited. The signing occurred on November 4, 2026, at 13:51:04 IST.